{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T21:06:13Z","timestamp":1775509573510,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM109090"],"award-info":[{"award-number":["P20GM109090"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM152301"],"award-info":[{"award-number":["P20GM152301"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Artificial Intelligence in Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.artmed.2025.103272","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:06:14Z","timestamp":1758585974000},"page":"103272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["AI-driven dynamic grouping for adaptive clinical trials: Rethinking randomization in precision medicine"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-0414","authenticated-orcid":false,"given":"Madhur","family":"Mangalam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.artmed.2025.103272_b1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJMsb1901642","article-title":"The magic of randomization versus the myth of real-world evidence","volume":"382","author":"Collins","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.artmed.2025.103272_b2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMra1614394","article-title":"Evidence for health decision making\u2014beyond randomized, controlled trials","volume":"377","author":"Frieden","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.artmed.2025.103272_b3","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","article-title":"Machine learning in medicine","volume":"132","author":"Deo","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.artmed.2025.103272_b4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41746-019-0148-3","article-title":"Artificial intelligence and machine learning in clinical development: A translational perspective","volume":"2","author":"Shah","year":"2019","journal-title":"Npj Digit Med"},{"issue":"2","key":"10.1016\/j.artmed.2025.103272_b5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12553-023-00738-2","article-title":"Artificial intelligence applied to clinical trials: Opportunities and challenges","volume":"13","author":"Askin","year":"2023","journal-title":"Heal Technol"},{"issue":"9","key":"10.1016\/j.artmed.2025.103272_b6","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/eurheartj\/ehae794","article-title":"Artificial intelligence and digital tools for design and execution of cardiovascular clinical trials","volume":"46","author":"Hu","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.artmed.2025.103272_b7","series-title":"Towards regulatory-confirmed adaptive clinical trials: Machine learning opportunities and solutions","author":"Klein","year":"2025"},{"key":"10.1016\/j.artmed.2025.103272_b8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41746-019-0090-4","article-title":"Developing and adopting safe and effective digital biomarkers to improve patient outcomes","volume":"2","author":"Coravos","year":"2019","journal-title":"Npj Digit Med"},{"key":"10.1016\/j.artmed.2025.103272_b9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41746-020-00314-2","article-title":"Challenges for the evaluation of digital health solutions\u2014A call for innovative evidence generation approaches","volume":"3","author":"Guo","year":"2020","journal-title":"Npj Digit Med"},{"issue":"1","key":"10.1016\/j.artmed.2025.103272_b10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/clpt.2009.68","article-title":"I-SPY 2: An adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy","volume":"86","author":"Barker","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.artmed.2025.103272_b11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra1510062","article-title":"Master protocols to study multiple therapies, multiple diseases, or both","volume":"377","author":"Woodcock","year":"2017","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.artmed.2025.103272_b12","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1001\/jama.2015.3595","article-title":"The precision medicine initiative: A new national effort","volume":"313","author":"Ashley","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.artmed.2025.103272_b13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nrc4015","article-title":"Precision medicine for cancer with next-generation functional diagnostics","volume":"15","author":"Friedman","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.artmed.2025.103272_b14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrd1927","article-title":"Bayesian clinical trials","volume":"5","author":"Berry","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.artmed.2025.103272_b15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1200\/JCO.2010.32.2685","article-title":"Adaptive clinical trials: The promise and the caution","volume":"29","author":"Berry","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.artmed.2025.103272_b16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-3-11","article-title":"Adaptive design methods in clinical trials\u2013a review","volume":"3","author":"Chow","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.artmed.2025.103272_b17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12916-018-1017-7","article-title":"Adaptive designs in clinical trials: Why use them, and how to run and report them","volume":"16","author":"Pallmann","year":"2018","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.artmed.2025.103272_b18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1513750","article-title":"Adaptive randomization of neratinib in early breast cancer","volume":"375","author":"Park","year":"2016","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.artmed.2025.103272_b19","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1001\/jama.2012.4174","article-title":"Adaptive clinical trials: A partial remedy for the therapeutic misconception?","volume":"307","author":"Meurer","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.artmed.2025.103272_b20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2147\/CLEP.S156708","article-title":"Critical concepts in adaptive clinical trials","volume":"10","author":"Park","year":"2018","journal-title":"Clin Epidemiology"},{"key":"10.1016\/j.artmed.2025.103272_b21","doi-asserted-by":"crossref","first-page":"k698","DOI":"10.1136\/bmj.k698","article-title":"Key design considerations for adaptive clinical trials: A primer for clinicians","volume":"360","author":"Thorlund","year":"2018","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.artmed.2025.103272_b22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jama.2022.24324","article-title":"Sequential, multiple assignment, randomized trial designs","volume":"329","author":"Kidwell","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.artmed.2025.103272_b23","series-title":"Principles and practice of clinical trials","first-page":"1543","article-title":"Sequential, multiple assignment, randomized trials (SMART)","author":"Seewald","year":"2022"},{"issue":"7","key":"10.1016\/j.artmed.2025.103272_b24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1513\/AnnalsATS.202003-192SD","article-title":"The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design","volume":"17","author":"Angus","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.artmed.2025.103272_b25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1158\/2159-8274.CD-10-0010","article-title":"The BATTLE trial: Personalizing therapy for lung cancer","volume":"1","author":"Kim","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.artmed.2025.103272_b26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41591-018-0310-5","article-title":"Guidelines for reinforcement learning in healthcare","volume":"25","author":"Gottesman","year":"2019","journal-title":"Nature Med"},{"issue":"1","key":"10.1016\/j.artmed.2025.103272_b27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/3477600","article-title":"Reinforcement learning in healthcare: A survey","volume":"55","author":"Yu","year":"2021","journal-title":"ACM Comput Surv"},{"issue":"5","key":"10.1016\/j.artmed.2025.103272_b28","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jbi.2009.08.007","article-title":"What can natural language processing do for clinical decision support?","volume":"42","author":"Demner-Fushman","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.artmed.2025.103272_b29","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1002\/jhm.2652","article-title":"Piloting electronic medical record\u2013based early detection of inpatient deterioration in community hospitals","volume":"11","author":"Escobar","year":"2016","journal-title":"J Hosp Med"},{"issue":"7","key":"10.1016\/j.artmed.2025.103272_b30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jamainternmed.2020.1318","article-title":"Commercial influences on electronic health records and adverse effects on clinical decision-making","volume":"180","author":"Taitsman","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"21","key":"10.1016\/j.artmed.2025.103272_b31","doi-asserted-by":"crossref","first-page":"7872","DOI":"10.1158\/1078-0432.CCR-05-0605","article-title":"Adaptive signature design: An adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients","volume":"11","author":"Freidlin","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.artmed.2025.103272_b32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1878-0261.12465","article-title":"New clinical trial designs in the era of precision medicine","volume":"13","author":"Garralda","year":"2019","journal-title":"Mol Oncol"},{"key":"10.1016\/j.artmed.2025.103272_b33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrd4694","article-title":"NCI-MATCH trial pushes cancer umbrella trial paradigm","volume":"14","author":"Mullard","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.artmed.2025.103272_b34","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/S2589-7500(20)30142-4","article-title":"Applications of digital technology in COVID-19 pandemic planning and response","volume":"2","author":"Whitelaw","year":"2020","journal-title":"Lancet Digit Heal"},{"issue":"5","key":"10.1016\/j.artmed.2025.103272_b35","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","article-title":"Personalized nutrition by prediction of glycemic responses","volume":"163","author":"Zeevi","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.artmed.2025.103272_b36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41591-018-0307-0","article-title":"The practical implementation of artificial intelligence technologies in medicine","volume":"25","author":"He","year":"2019","journal-title":"Nature Med"},{"issue":"9","key":"10.1016\/j.artmed.2025.103272_b37","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/sim.5686","article-title":"Methods for dealing with time-dependent confounding","volume":"32","author":"Daniel","year":"2013","journal-title":"Stat Med"},{"issue":"5","key":"10.1016\/j.artmed.2025.103272_b38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.artmed.2025.103272_b39","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1541-0420.2005.00377.x","article-title":"Doubly robust estimation in missing data and causal inference models","volume":"61","author":"Bang","year":"2005","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.artmed.2025.103272_b40","first-page":"756","article-title":"An introduction to g methods","volume":"46","author":"Naimi","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"455","key":"10.1016\/j.artmed.2025.103272_b41","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1198\/016214501753208573","article-title":"Balanced risk set matching","volume":"96","author":"Li","year":"2001","journal-title":"J Amer Statist Assoc"},{"issue":"3","key":"10.1016\/j.artmed.2025.103272_b42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1541-0420.2005.00356.x","article-title":"Propensity score matching with time-dependent covariates","volume":"61","author":"Lu","year":"2005","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.artmed.2025.103272_b43","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jamia\/ocaa268","article-title":"Trust and medical AI: The challenges we face and the expertise needed to overcome them","volume":"28","author":"Quinn","year":"2021","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.artmed.2025.103272_b44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: The convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nature Med"},{"issue":"10","key":"10.1016\/j.artmed.2025.103272_b45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013302","article-title":"Developing a simplified consent form for biobanking","volume":"5","author":"Beskow","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.artmed.2025.103272_b46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/gim.2015.33","article-title":"Interactive multimedia consent for biobanking: A randomized trial","volume":"18","author":"Simon","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.artmed.2025.103272_b47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12910-016-0162-9","article-title":"Dynamic consent: A potential solution to some of the challenges of modern biomedical research","volume":"18","author":"Budin-Lj\u00f8sne","year":"2017","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.artmed.2025.103272_b48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ejhg.2014.71","article-title":"Dynamic consent: A patient interface for twenty-first century research networks","volume":"23","author":"Kaye","year":"2015","journal-title":"Eur J Human Genet"},{"key":"10.1016\/j.artmed.2025.103272_b49","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ejhg.2012.282","article-title":"Broad consent versus dynamic consent in biobank research: Is passive participation an ethical problem?","volume":"21","author":"Steinsbekk","year":"2013","journal-title":"Eur J Human Genet"},{"issue":"6464","key":"10.1016\/j.artmed.2025.103272_b50","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1126\/science.aax2342","article-title":"Dissecting racial bias in an algorithm used to manage the health of populations","volume":"366","author":"Obermeyer","year":"2019","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.artmed.2025.103272_b51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002689","article-title":"Machine learning in medicine: Addressing ethical challenges","volume":"15","author":"Vayena","year":"2018","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.artmed.2025.103272_b52","doi-asserted-by":"crossref","first-page":"e745","DOI":"10.1016\/S2589-7500(21)00208-9","article-title":"The false hope of current approaches to explainable artificial intelligence in health care","volume":"3","author":"Ghassemi","year":"2021","journal-title":"Lancet Digit Heal"},{"key":"10.1016\/j.artmed.2025.103272_b53","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s42256-019-0048-x","article-title":"Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead","volume":"1","author":"Rudin","year":"2019","journal-title":"Nat Mach Intell"},{"issue":"6470","key":"10.1016\/j.artmed.2025.103272_b54","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.aay9547","article-title":"Algorithms on regulatory lockdown in medicine","volume":"366","author":"Babic","year":"2019","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.artmed.2025.103272_b55","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/cpt.1658","article-title":"Examining the use of real-world evidence in the regulatory process","volume":"107","author":"Beaulieu-Jones","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"23","key":"10.1016\/j.artmed.2025.103272_b56","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence\u2014what is it and what can it tell us","volume":"375","author":"Sherman","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.artmed.2025.103272_b57","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/1740774515626362","article-title":"Efficiencies of platform clinical trials: A vision of the future","volume":"13","author":"Saville","year":"2016","journal-title":"Clin Trials"},{"key":"10.1016\/j.artmed.2025.103272_b58","doi-asserted-by":"crossref","first-page":"780","DOI":"10.12688\/gatesopenres.12912.2","article-title":"Highly efficient clinical trials simulator (HECT): Software application for planning and simulating platform adaptive trials","volume":"3","author":"Thorlund","year":"2019","journal-title":"Gates Open Res"},{"issue":"1","key":"10.1016\/j.artmed.2025.103272_b59","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/s13063-021-05453-9","article-title":"The NUDGE trial pragmatic trial to enhance cardiovascular medication adherence: Study protocol for a randomized controlled trial","volume":"22","author":"Glasgow","year":"2021","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.artmed.2025.103272_b60","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/jamia\/ocae017","article-title":"Artificial intelligence predictive analytics in heart failure: Results of the pilot phase of a pragmatic randomized clinical trial","volume":"31","author":"Sideris","year":"2024","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"10.1016\/j.artmed.2025.103272_b61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/17460441.2023.2273839","article-title":"Generative artificial intelligence empowers digital twins in drug discovery and clinical trials","volume":"19","author":"Bordukova","year":"2024","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.artmed.2025.103272_b62","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41746-024-01073-0","article-title":"Digital twins for health: A scoping review","volume":"7","author":"Katsoulakis","year":"2024","journal-title":"Npj Digit Med"},{"issue":"8","key":"10.1016\/j.artmed.2025.103272_b63","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jamainternmed.2021.2626","article-title":"External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients","volume":"181","author":"Wong","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.artmed.2025.103272_b64","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/1740774515598334","article-title":"Exploring the ethical and regulatory issues in pragmatic clinical trials","volume":"12","author":"Califf","year":"2015","journal-title":"Clin Trials"}],"container-title":["Artificial Intelligence in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0933365725002076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0933365725002076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:19:41Z","timestamp":1773109181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0933365725002076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":64,"alternative-id":["S0933365725002076"],"URL":"https:\/\/doi.org\/10.1016\/j.artmed.2025.103272","relation":{},"ISSN":["0933-3657"],"issn-type":[{"value":"0933-3657","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-driven dynamic grouping for adaptive clinical trials: Rethinking randomization in precision medicine","name":"articletitle","label":"Article Title"},{"value":"Artificial Intelligence in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.artmed.2025.103272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103272"}}